TL;DR
These findings validate the superiority and accuracy of MBVEGFR2-based USMI for microvessel imaging and monitoring of angiogenesis in cervical cancer compared with SMI and MBCon and remain an alternative to microvessels imaging when ultrasonic contrast agent use is contraindicated.
AI-generated by Semantic Scholar